Bridgeway Capital Management, LLC Pmv Pharmaceuticals, Inc. Transaction History
Bridgeway Capital Management, LLC
- $4.76 Billion
- Q1 2024
A detailed history of Bridgeway Capital Management, LLC transactions in Pmv Pharmaceuticals, Inc. stock. As of the latest transaction made, Bridgeway Capital Management, LLC holds 75,000 shares of PMVP stock, worth $117,000. This represents 0.0% of its overall portfolio holdings.
Number of Shares
75,000
Previous 194,900
61.52%
Holding current value
$117,000
Previous $604,000
78.97%
% of portfolio
0.0%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding PMVP
# of Institutions
106Shares Held
45.5MCall Options Held
2KPut Options Held
600-
Orbimed Advisors LLC San Diego, CA6.48MShares$10.1 Million0.25% of portfolio
-
Arrow Mark Colorado Holdings LLC Denver, CO3.2MShares$4.99 Million0.07% of portfolio
-
Black Rock Inc. New York, NY3.11MShares$4.85 Million0.0% of portfolio
-
Euclidean Capital LLC New York, NY2.63MShares$4.1 Million0.57% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.45MShares$3.83 Million0.0% of portfolio
About PMV Pharmaceuticals, Inc.
- Ticker PMVP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,622,600
- Market Cap $71.2M
- Description
- PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also d...